MetaCap

Bio-Rad Laboratories (BIO) vs Nautilus Biotechnology (NAUT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bio-Rad Laboratories (BIO) has outperformed Nautilus Biotechnology (NAUT) over the past year, gaining 13.3% versus a loss of 5.4%. Over five years, BIO leads with a -52.2% price change compared with -56.4% for NAUT. Bio-Rad Laboratories is the larger company by market cap ($9.65 billion vs $270.0 million), about 35.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BIO+13.32%NAUT-5.36%
+83%+7%-69%
Nov 21, 20251 yearNov 20, 2026
BIO-53.79%NAUT-57.68%
+26%-33%-92%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BIO versus NAUT key metrics
MetricBIONAUT
Share price$358.90$2.12
Market cap$9.65B$270.03M
1-day change-2.34%-2.30%
YTD return+18.45%+8.72%
1-year return+13.32%-5.36%
5-year return-52.16%-56.38%
P/E ratio (TTM)9.54—
Forward P/E36.23—
EPS (TTM)$37.64$-0.46
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.58B—
Revenue growth (YoY)+0.65%—
Net income (latest FY)$759.90M$-59.00M
Gross margin51.87%—
Operating margin1.83%—
Net margin29.42%—
52-week high$396.23$4.31
52-week low$236.73$0.841
Distance from 52-week high-9.42%-50.81%
Analyst consensusholdnone
Avg. price target upside-0.62%+88.68%
Average volume257.70K6.25M
Shares outstanding21.83M127.37M
Employees7,450128
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Bio-Rad Laboratories is about 35.7 times larger than Nautilus Biotechnology by market value ($9.65B vs $270.03M).
  • BIO has outperformed NAUT by 18.7 percentage points over the past year.

About Bio-Rad Laboratories

BIO stock →

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

Industrials · Biotechnology: Laboratory Analytical Instruments · 7,450 employees

About Nautilus Biotechnology

NAUT stock →

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.

Industrials · Biotechnology: Laboratory Analytical Instruments · 128 employees

BIO vs NAUT FAQ

Which is bigger, Bio-Rad Laboratories or Nautilus Biotechnology?

Bio-Rad Laboratories (BIO) is larger, with a market capitalization of $9.65B compared with $270.03M for Nautilus Biotechnology (NAUT).

Which stock has performed better over the past year, BIO or NAUT?

BIO returned +13.32% over the past 12 months, compared with -5.36% for NAUT (price return, excluding dividends). Past performance does not predict future results.

Are Bio-Rad Laboratories and Nautilus Biotechnology in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons